Bobae Kim - Jun 7, 2023 Form 4 Insider Report for Bellerophon Therapeutics, Inc. (BLPH)

Role
VP Reg. Affairs & Quality
Signature
/s/ Bobae Kim
Stock symbol
BLPH
Transactions as of
Jun 7, 2023
Transactions value $
$0
Form type
4
Date filed
6/9/2023, 04:10 PM
Previous filing
May 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLPH Stock Options (Right to Buy) Award $0 -50K -50% $0.00 50K Jun 7, 2023 Common Stock 50K $0.83 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was approved by the Compensation Committee of the Board of Directors of Bellerophon Therapeutics, Inc., on February 10, 2023, contingent upon stockholder approval of an amendment to the Company's 2015 Equity Incentive Plan under which the options were granted, which was approved by stockholders on June 7, 2023.
F2 This option vests in 16 quarterly installments commencing on the date hereof.